Leonteq Securities’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
Leonteq Securities's AUPH Position: Q3 2026 in Review
Leonteq Securities held its Aurinia Pharmaceuticals (AUPH) position steady in Q3 2026 at 1,891 shares worth $30.6K. The position accounts for ﹤0.01% of the portfolio, ranked #863.
Leonteq Securities first reported a position in AUPH in Q1 2021 and has held it in 23 quarters since. The position peaked at $3.62M in Q4 2021. 214 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.
- Leonteq Securities held 1,891 shares of Aurinia Pharmaceuticals worth $30.6K as of Q3 2026.
- Leonteq Securities left its Aurinia Pharmaceuticals share count unchanged in Q3 2026.
- Aurinia Pharmaceuticals made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #863 holding.
- Leonteq Securities first reported a position in Aurinia Pharmaceuticals in Q1 2021 and has held it in 23 quarters since.
- Leonteq Securities's Aurinia Pharmaceuticals position peaked at $3.62M in Q4 2021.
- 214 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.